JNJ · Dividend Triangle

5-year compound growth across Revenue, , and Dividend — the three legs that decide whether a payout is sustainable.

JNJ · DiviDrip Dividend Triangle Scorecard
Snapshot date: Jul 16, 2026
Johnson & Johnson · $253.85
Dividend Triangle Score
72/100
Healthy growth profile
  • of 60% leaves comfortable room for both reinvestment and future dividend hikes.
  • of 16.6% — management is deploying capital efficiently, a long-term tailwind for dividend reliability.
: 7.32 (needs ≥15)2.07% yield + 5.25% 5-yr CAGR = 7.32. Low-yield growth (yield <3%, needs ≥15).
  • coverage1.39xtarget >1.5x

    Coverage is thin — a bad quarter could squeeze the dividend.

  • 60.2%target <60%

    Stretched — the next hike will be small or paused.

  • Dividend streak64 yr (Aristocrat+)target ≥5 yr

    25+ year streak survived multiple recessions.

  • Leverage ()0.68target <1.5

    Debt load is in the safe zone for this sector.

  • Yield in sector range2.07%target 1.0–4.0%

    Yield is normal for Healthcare.

3/5 passed — Pause and investigate — write your thesis first.

Rule of thumb: 5/5 = buy with conviction · 4/5 = smaller position · 3/5 = investigate and write your thesis · ≤2/5 = walk away.

DiviDrip's Opinion

Not to BuyDividend Stock

Coverage is stretched and earnings are heading the wrong way.

  • EPS down 21.7% — earnings shrinking.

What changes our mind: Payout coming back under 60% with positive EPS growth and FCF coverage under 70% would warrant another look.

DiviDrip's Opinion is an educational signal based on public financials, not financial advice. Always do your own research.

RevenueEPSDividend0255075100
Revenue
+2.6%
n=7.99yr CAGR
EPS
+48.4%
n=7.99yr CAGR
Dividend
+6.4%
n=4yr CAGR

Source: Massive.com · Cached 24h · Dividend Triangle is for educational use, not investment advice.

The Dividend Triangle is an educational visualization. It is not investment advice and does not replace your own research or a conversation with a licensed financial advisor.

Made with Emergent